AXSM vs. BKV
AXSM (Axsome Therapeutics, Inc.) and BKV (BKV Corp) are both stocks. AXSM operates in Biotechnology (Healthcare), while BKV operates in Oil & Gas E&P (Energy). Over the past year, AXSM returned 115.02% vs 18.51% for BKV. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
AXSM vs. BKV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AXSM achieves a 19.36% return, which is significantly higher than BKV's -9.91% return.
AXSM
- 1D
- -7.10%
- 1M
- -9.42%
- 6M
- 18.31%
- YTD
- 19.36%
- 1Y
- 115.02%
- 3Y*
- 41.26%
- 5Y*
- 35.01%
- 10Y*
- 39.83%
- ALL TIME*
- 34.71%
BKV
- 1D
- 1.62%
- 1M
- -10.07%
- 6M
- -17.78%
- YTD
- -9.91%
- 1Y
- 18.51%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 16.19%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $153.10M | $171.36M | $209.26M | |
BKV BKV Corp | $23.05M | $20.19M | $22.46M |
AXSM vs. BKV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 19.36% | 115.86% | -5.91% |
BKV BKV Corp | -9.91% | 14.17% | 28.19% |
Correlation
The correlation between AXSM and BKV is 0.15, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.15 |
Correlation (All Time) Calculated using the full available price history since Sep 26, 2024 | 0.13 |
Fundamentals
AXSM:
$11.22B
BKV:
$2.68B
AXSM:
-$3.72
BKV:
$3.17
AXSM:
15.58
BKV:
2.11
AXSM:
204.46
BKV:
1.08
AXSM:
$708.24M
BKV:
$1.08B
AXSM:
$655.82M
BKV:
$693.49M
AXSM:
-$172.72M
BKV:
$544.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AXSM vs. BKV — Risk / Return Rank
AXSM
BKV
AXSM vs. BKV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and BKV Corp (BKV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AXSM | BKV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.25 | ||
| Sortino ratioReturn per unit of downside risk | +3.04 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 1.11 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 6.25 | 0.68 | +5.58 |
| Martin ratioReturn relative to average drawdown | 18.02 | 1.68 | +16.34 |
Loading charts...
Drawdowns
AXSM vs. BKV - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, which is greater than BKV's maximum drawdown of -39.98%. Use the drawdown chart below to compare losses from any high point for AXSM and BKV.
Loading charts...
Drawdown Indicators
| AXSM | BKV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.65% | -39.98% | -46.67% |
Max Drawdown (1Y)Largest decline over 1 year | -18.50% | -27.52% | +9.02% |
Max Drawdown (3Y)Largest decline over 3 years | -32.69% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -61.08% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -81.26% | — | — |
Current DrawdownCurrent decline from peak | -14.57% | -23.94% | +9.37% |
Average DrawdownAverage peak-to-trough decline | -39.06% | -12.15% | -26.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.41% | 11.07% | -4.66% |
Volatility
AXSM vs. BKV - Volatility Comparison
Axsome Therapeutics, Inc. (AXSM) has a higher volatility of 14.94% compared to BKV Corp (BKV) at 10.10%. This indicates that AXSM's price experiences larger fluctuations and is considered to be riskier than BKV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AXSM | BKV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.94% | 10.10% | +4.84% |
Volatility (6M)Calculated over the trailing 6-month period | 28.72% | 26.67% | +2.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.96% | 41.73% | +1.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.11% | 42.88% | +27.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.38% | 42.88% | +47.50% |
Dividends
AXSM vs. BKV - Dividend Comparison
Neither AXSM nor BKV has paid dividends to shareholders.
Financials
AXSM vs. BKV - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and BKV Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXSM vs. BKV - Profitability Comparison
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
BKV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, BKV Corp reported a gross profit of 405.49M and revenue of 432.85M. Therefore, the gross margin over that period was 93.7%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
BKV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, BKV Corp reported an operating income of 86.03M and revenue of 432.85M, resulting in an operating margin of 19.9%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
BKV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, BKV Corp reported a net income of 44.08M and revenue of 432.85M, resulting in a net margin of 10.2%.
Frequently Asked Questions
AXSM and BKV have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXSM has higher volatility (14.94%) compared to BKV (10.10%). In terms of maximum drawdown, AXSM dropped -86.65% vs BKV's -39.98%.
AXSM currently has the higher Sharpe Ratio (2.69 vs 0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AXSM and BKV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer